Clinical Trial Update: Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a dendritic cell–based HIV vaccine pulsed with chemically inactivated virus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dendritic cell-based HIV vaccine pulsed with chemically inactivated virus

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: HIV Infection | Phase 1, Phase 2 | Status: COMPLETED